BioNTech SE (BNTX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 120.04M | 898.89M | 1.52B | 260.8M | 182.8M | 1.19B | 1.24B | 128.7M | 187.6M | 1.48B | 895.3M | 167.7M |
| Revenue Growth % | -34.33% | -24.46% | 22.02% | 102.64% | -2.56% | -19.54% | 39.04% | -23.26% | -85.31% | -65.43% | -74.13% | -94.75% |
| Cost of Goods Sold | 195.87M | 330.17M | 148.3M | 76.4M | 83.8M | 243.5M | 178.9M | 59.8M | 59.1M | 179.1M | 161.8M | 162.9M |
| COGS % of Revenue | 163.17% | 36.73% | 9.76% | 29.29% | 45.84% | 20.46% | 14.37% | 46.46% | 31.5% | 12.11% | 18.07% | 97.14% |
| Gross Profit | -75.83M | 568.72M | 1.37B | 184.4M | 99M | 946.5M | 1.07B | 68.9M | 128.5M | 1.3B | 733.5M | 4.8M |
| Gross Margin % | -63.17% | 63.27% | 90.24% | 70.71% | 54.16% | 79.54% | 85.63% | 53.54% | 68.5% | 87.89% | 81.93% | 2.86% |
| Gross Profit Growth % | -176.59% | -39.91% | 28.59% | 167.63% | -22.96% | -27.19% | 45.32% | 1335.42% | -89.12% | -68.25% | -72.92% | -99.8% |
| Operating Expenses | 596.14M | 799.33M | 1.42B | 685.5M | 633.1M | 797.9M | 1.06B | 1.04B | 635.7M | 773.7M | 660.4M | 568.1M |
| OpEx % of Revenue | 496.61% | 88.92% | 93.32% | 262.85% | 346.33% | 67.05% | 84.78% | 804.27% | 338.86% | 52.31% | 73.76% | 338.76% |
| Selling, General & Admin | 150.8M | 291.7M | 148.5M | 137.4M | 120.6M | 132.1M | 150.5M | 183.8M | 132.6M | 149.4M | 153.5M | 137.9M |
| SG&A % of Revenue | 125.62% | 32.45% | 9.78% | 52.68% | 65.97% | 11.1% | 12.09% | 142.81% | 70.68% | 10.1% | 17.15% | 82.23% |
| Research & Development | 566.16M | 500.66M | 564.8M | 509.1M | 525.6M | 611.8M | 550.3M | 584.6M | 507.5M | 577.8M | 497.9M | 373.4M |
| R&D % of Revenue | 471.63% | 55.7% | 37.18% | 195.21% | 287.53% | 51.41% | 44.21% | 454.23% | 270.52% | 39.07% | 55.61% | 222.66% |
| Other Operating Expenses | -1000K | 1000K | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K |
| Operating Income | -671.97M | -230.62M | -46.9M | -501.1M | -534.1M | 148.6M | 10.5M | -966.2M | -507.2M | 526.2M | 73.1M | -563.3M |
| Operating Margin % | -559.78% | -25.66% | -3.09% | -192.14% | -292.18% | 12.49% | 0.84% | -750.74% | -270.36% | 35.58% | 8.16% | -335.9% |
| Operating Income Growth % | -25.81% | -255.19% | -546.67% | 48.14% | -5.3% | -71.76% | -85.64% | -71.52% | -177.51% | -84.02% | -96.94% | -125.49% |
| EBITDA | -548.68M | -67.36M | 77.3M | -450.1M | -491.3M | 314M | 54.9M | -916.3M | -468.9M | 605M | 114.4M | -531.4M |
| EBITDA Margin % | -457.07% | -7.49% | 5.09% | -172.58% | -268.76% | 26.39% | 4.41% | -711.97% | -249.95% | 40.91% | 12.78% | -316.88% |
| EBITDA Growth % | -11.68% | -121.45% | 40.8% | 50.88% | -4.78% | -48.1% | -52.01% | -72.43% | -168.37% | -81.79% | -95.27% | -123.69% |
| D&A (Non-Cash Add-back) | 123.29M | 163.25M | 124.2M | 51M | 42.8M | 165.4M | 44.4M | 49.9M | 38.3M | 78.8M | 41.3M | 31.9M |
| EBIT | -573.38M | -218.83M | 25.1M | -399.3M | -411.5M | 299M | 166.7M | -802.4M | -327.1M | 376.8M | 229.4M | -410.9M |
| Net Interest Income | 58.65M | 253.7M | -399.08K | -3.29M | -6.22M | 0 | -5.21M | 160.9M | 177.14M | 133.88M | 159.18M | 150.78M |
| Interest Income | 62.71M | 260.14M | 0 | 0 | 0 | 0 | 0 | 168.22M | 181.89M | 152.84M | 161.25M | 152.08M |
| Interest Expense | 4.07M | 6.44M | 399.08K | 3.29M | 6.22M | 0 | 5.21M | 7.32M | 4.75M | 18.96M | 2.06M | 1.3M |
| Other Income/Expense | 94.53M | 5.35M | 71.6M | 98.4M | 88.7M | 152.6M | 148.2M | 160.4M | 175.4M | 137M | 154.3M | 151.1M |
| Pretax Income | -577.44M | -225.27M | 24.7M | -402.7M | -445.4M | 301.2M | 158.7M | -805.8M | -331.8M | 663.2M | 227.4M | -412.2M |
| Pretax Margin % | -481.03% | -25.06% | 1.63% | -154.41% | -243.65% | 25.31% | 12.75% | -626.11% | -176.87% | 44.84% | 25.4% | -245.8% |
| Income Tax | -36.8M | 76.87M | 53.4M | -16.1M | -29.6M | 41.7M | -39.4M | 2M | -16.7M | 205.3M | 66.8M | -221.8M |
| Effective Tax Rate % | 6.37% | -34.12% | 216.19% | 4% | 6.65% | 13.84% | -24.83% | -0.25% | 5.03% | 30.96% | 29.38% | 53.81% |
| Net Income | -540.65M | -302.14M | -28.7M | -386.6M | -415.8M | 259.5M | 198.1M | -807.8M | -315.1M | 457.9M | 160.6M | -190.4M |
| Net Margin % | -450.38% | -33.61% | -1.89% | -148.24% | -227.46% | 21.81% | 15.91% | -627.66% | -167.96% | 30.96% | 17.94% | -113.54% |
| Net Income Growth % | -30.03% | -216.43% | -114.49% | 52.14% | -31.96% | -43.33% | 23.35% | -324.26% | -162.74% | -79.91% | -91% | -111.39% |
| Net Income (Continuing) | -540.65M | -302.14M | -28.7M | -386.6M | -415.8M | 259.5M | 198.1M | -807.8M | -315.1M | 457.9M | 160.6M | -190.4M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.14 | -1.23 | -0.12 | -1.60 | -1.73 | 1.08 | 0.81 | -3.42 | -1.31 | 1.84 | 0.69 | -0.79 |
| EPS Growth % | -23.7% | -213.89% | -114.81% | 53.22% | -32.06% | -41.3% | 17.39% | -332.91% | -164.53% | -79.16% | -90.11% | -112.25% |
| EPS (Basic) | -2.14 | -1.23 | -0.12 | -1.60 | -1.73 | 1.08 | 0.83 | -3.42 | -1.31 | 1.88 | 0.69 | -0.79 |
| Diluted Shares Outstanding | 252.88M | 245.16M | 239.17M | 241.63M | 240.35M | 240.28M | 244.57M | 237.73M | 240.53M | 241M | 239.7M | 239.77M |
| Basic Shares Outstanding | 252.88M | 245.16M | 239.17M | 241.63M | 240.35M | 240.28M | 239.74M | 237.73M | 240.53M | 237.73M | 239.7M | 239.77M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |